We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Instrument Automates Droplet Generation for Digital Droplet PCR Systems

By LabMedica International staff writers
Posted on 09 Nov 2014
Bio-Rad\'s AutoDG Droplet Generator with the QX200 Droplet Digital PCR System
The AutoDG Droplet Generator (left) with the QX200 Droplet Digital PCR System (right) (Photo courtesy of BIO-RAD LABORATORIES)
Biotech researchers and other life scientists working with PCR techniques will be interested in the availability of a new instrument that automates and standardizes droplet generation for droplet digital PCR (ddPRC).

Bio-Rad Laboratories, Inc. (Hercules, CA, USA) has launched its Automated Droplet Generator (AutoDG Instrument) that complements the QX100 and QX200 Droplet Readers. This combination of instruments and a laptop computer equipped with the QuantaSoft software package constitute the automated droplet digital PCR system.

The AutoDG Instrument creates droplets quickly, reproducibly, and reliably. At maximum capacity, the system can generate droplets for 96 wells in less than 45 minutes. The instrument can generate droplets for fluorescent probe-based or EvaGreen dye-based detection.

The Droplet Generator is used to partition the ddPCR reaction mix into 20,000 nanoliter-sized droplets. After PCR on a thermal cycler, droplets from each sample are analyzed individually on the Droplet Reader. Droplets are sipped, and the singulator unpacks the emulsified droplets and streams them in single file past a two-color optical detection system in a serial manner. Up to 96 samples can be processed per run. The PCR-positive and PCR-negative droplets are counted to provide absolute quantification of target DNA in digital form. Alternatively, amplified products can be extracted from droplets following PCR for downstream applications, such as sequencing or cloning.

The AutoDG Instrument has its own hood and HEPA filter, reducing contamination so the system can be used on a standard laboratory bench, without the need for a PCR cabinet or cleanroom.

Bio-Rad's digital biology center marketing managers said, "With a quick setup, you are able to walk away and return to a full plate of droplets ready for thermal cycling and analysis. Droplet Digital PCR is sensitive enough to detect differences in people’s pipetting habits. This instrument eliminates that variability."

Related Links:

Bio-Rad Laboratories, Inc.


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Aliquoting Pipet Controller
ALI-Q 2 Series
New
Urine Microscopy Analyzer
DxU 850m Iris
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The partnership with LLS expands access to Lucent’s non-invasive blood-based biomarker tests for early detection of cognitive diseases (photo courtesy of Adobe Stock)

New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
INTEGRA BIOSCIENCES AG